Foghorn Therapeutics furnishes June 2024 investor presentation; no specific financial data disclosed

Foghorn Therapeutics Inc.

Presentation dated June 2024 was made available under Regulation FD.
No new financial or operational metrics were included in the filing.
The presentation is intended for use in investor meetings.
Company ticker FHTX; traded on Nasdaq.

item 7.01 item 9.01

Foghorn Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-026294

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.